Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Primary Care POC Diagnostics market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Primary Care POC Diagnostics market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
The Primary Care POC Diagnostics market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Primary Care POC Diagnostics products across developed and developing countries of the world.
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Primary Care POC Diagnostics products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Primary Care POC Diagnostics market.
To learn more about this report
Increasing research and development spending on Primary Care POC Diagnostics development has been the leading industry trend of Primary Care POC Diagnostics market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
To learn more about this report
| Report Attributes | Details |
| The market size value in 2021 | USD XX.XX Million |
| CAGR (2021 - 2028) | XX.XX % |
| The Revenue forecast in 2028 | USD XX.XX Million |
| Base year for estimation | 2021 |
| Historical data | 2018-2019 |
| Forecast period | 2022-2028 |
| Quantitative units |
|
| Report coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered | By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook | Glucose Testing, Hb1Ac, Coagulation, Fertility |
| By Application Outlook | Pharmacy & Retail Clinics, Physician Office, Urgent Care Clinics, Non-practice Clinics, Cardiac Markers |
| Regional scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope | U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled | Abbott, ADI/American Diagnostica, Agilent Technologies, Alere/Biosite/Inverness, Axis-Shield, Beckman Coulter/Danaher, Becton Dickinson, Bio/Data, Decode Genetics, Diadexus, Diagnocure, Diagnostica Stago/Trinity Biotech, Diamedix, Polymedco, Qiagen, Roche, SDIX, Sequenom, Siemens, Sienco, Sysmex, Takara Bio, ThermoFisher, Tosoh, Wako, Zycare/Alere |
| Customization Available | Yes, the report can be tailored to meet your specific requirements. |
1 Methodology and Scope
1.1 Market segmentation & scope
1.2 Information Procurement
1.2.1 Purchased Database
1.2.2 Eternity’s Internal Database
1.2.3 Secondary sources & third-party perspectives
1.2.4 Primary Research
1.3 Information analysis
1.4 Market formulation & data visualization
1.5 Data validation & publishing
2 Executive Summary
3 Primary Care POC Diagnostics Market Variables, Trends & Scope
3.1 Market Dynamics
3.1.1 Market Driver Analysis
3.1.2 Market Restraints
3.1.3 Market Challenge Analysis
3.1.4 Market Opportunities
3.1.5 Micro & Macro Indicator
3.2 Impact of COVID-19 Pandemic on Global Primary Care POC Diagnostics Market
3.2.1 Overview of Changing Landscape
3.2.2 Pre-covid & Post-Covid Market Analysis
3.3 Market Attractiveness Analysis
3.4 Regulatory Scenario
3.5 Industry Trend Analysis- Historic and Future Trend Assessment
3.6 Merger & Acquisition
3.7 New System Launch/Approvals
3.8 Market Analysis Tools
3.8.1 Porter’s Five Forces
3.8.2 PEST Analysis
3.8.3 Value Chain Analysis
3.9 Key Company Ranking Analysis, 2020
4 Global Primary Care POC Diagnostics Market Analysis and Forecast, By Type
4.1 Overview & Definition
4.2 Key Trends
4.3 Global Primary Care POC Diagnostics Market Value (US$ Mn) Forecast, by Type (2019 – 2028)
4.2.1 Glucose Testing
4.2.2 Hb1Ac
4.2.3 Coagulation
4.2.4 Fertility
4.4 Type Comparison Matrix
4.5 Global Primary Care POC Diagnostics Market Attractiveness, By Type
5 Global Primary Care POC Diagnostics Market Analysis and Forecast, By Application
5.1 Overview & Definition
5.2 Key Trends
5.3 Global Primary Care POC Diagnostics Market Value (US$ Mn) Forecast, by Application (2019 – 2028)
5.3.1 Pharmacy & Retail Clinics
5.3.2 Physician Office
5.3.3 Urgent Care Clinics
5.3.4 Non-practice Clinics
5.3.5 Cardiac Markers
5.4 Application Comparison Matrix
5.5 Global Primary Care POC Diagnostics Market Attractiveness, by Application
6 Global Primary Care POC Diagnostics Market Analysis and Forecast, By Region
6.1 Overview & Definition
6.2 Key Trends
6.3 Global Primary Care POC Diagnostics Market Value (US$ Mn) Forecast, by Region (2019 – 2028)
6.4 North America
6.5 Europe
6.6 Asia Pacific
6.7 Latin America
6.8 Middle East & Africa
7 Global Primary Care POC Diagnostics Market Attractiveness, by Region
8 North America Primary Care POC Diagnostics Market Analysis and Forecast
8.1 Key Findings
8.2 North America Primary Care POC Diagnostics Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
8.2.1 Glucose Testing
8.2.2 Hb1Ac
8.2.3 Coagulation
8.2.4 Fertility
8.3 North America Primary Care POC Diagnostics Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
8.3.1 Pharmacy & Retail Clinics
8.3.2 Physician Office
8.3.3 Urgent Care Clinics
8.3.4 Non-practice Clinics
8.3.5 Cardiac Markers
8.4 North America Primary Care POC Diagnostics Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
8.4.1 U.S.
8.4.2 Canada
8.4.3 Rest of North America
8.5 North America Primary Care POC Diagnostics Market Attractiveness Analysis
8.5.1 By Type
8.5.2 By Application
8.5.3 By Country
9 Europe Primary Care POC Diagnostics Market Analysis and Forecast
9.1 Key Findings
9.2 Europe Primary Care POC Diagnostics Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
9.2.1 Glucose Testing
9.2.2 Hb1Ac
9.2.3 Coagulation
9.2.4 Fertility
9.3 Europe Primary Care POC Diagnostics Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
9.3.1 Pharmacy & Retail Clinics
9.3.2 Physician Office
9.3.3 Urgent Care Clinics
9.3.4 Non-practice Clinics
9.3.5 Cardiac Markers
9.4 Europe Primary Care POC Diagnostics Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
9.4.1 U.K.
9.4.2 Germany
9.4.3 France
9.4.4 Italy
9.4.5 Rest of Europe
9.5 Europe Primary Care POC Diagnostics Market Attractiveness Analysis
9.5.1 By Type
9.5.2 By Application
9.5.3 By Country
10 Asia Pacific Primary Care POC Diagnostics Market Analysis and Forecast
10.1 Key Findings
10.2 Asia Pacific Primary Care POC Diagnostics Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
10.2.1 Glucose Testing
10.2.2 Hb1Ac
10.2.3 Coagulation
10.2.4 Fertility
10.3 Asia Pacific Primary Care POC Diagnostics Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
10.3.1 Pharmacy & Retail Clinics
10.3.2 Physician Office
10.3.3 Urgent Care Clinics
10.3.4 Non-practice Clinics
10.3.5 Cardiac Markers
10.4 Asia Pacific Primary Care POC Diagnostics Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
10.4.1 China
10.4.2 India
10.4.3 Japan
10.4.4 South Korea
10.4.5 Rest of APAC
10.5 Asia Pacific Primary Care POC Diagnostics Market Attractiveness Analysis
10.5.1 By Type
10.5.2 By Application
10.5.3 By Country
11 Latin America Primary Care POC Diagnostics Market Analysis and Forecast
11.1 Key Findings
11.2 Latin America Primary Care POC Diagnostics Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
11.2.1 Glucose Testing
11.2.2 Hb1Ac
11.2.3 Coagulation
11.2.4 Fertility
11.3 Latin America Primary Care POC Diagnostics Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
11.3.1 Pharmacy & Retail Clinics
11.3.2 Physician Office
11.3.3 Urgent Care Clinics
11.3.4 Non-practice Clinics
11.3.5 Cardiac Markers
11.4 Latin America Primary Care POC Diagnostics Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
11.4.1 Brazil
11.4.2 Rest of Latin America China
11.5 Latin America Primary Care POC Diagnostics Market Attractiveness Analysis
11.5.1 By Type
11.5.2 By Application
11.5.3 By Country
12 Middle East & Africa (MEA) Primary Care POC Diagnostics Market Analysis and Forecast
12.1 Key Findings
12.2 Middle East & Africa (MEA) Primary Care POC Diagnostics Market Analysis (US$ Mn) and Forecast, By Product Type (2019-2028)
12.2.1 Glucose Testing
12.2.2 Hb1Ac
12.2.3 Coagulation
12.2.4 Fertility
12.3 Middle East & Africa (MEA) Primary Care POC Diagnostics Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
12.3.1 Pharmacy & Retail Clinics
12.3.2 Physician Office
12.3.3 Urgent Care Clinics
12.3.4 Non-practice Clinics
12.3.5 Cardiac Markers
12.4 Middle East & Africa (MEA) Primary Care POC Diagnostics Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
12.4.1 GCC Countries
12.4.2 South Africa
12.4.3 Rest of MEA
12.5 Middle East & Africa (MEA) Primary Care POC Diagnostics Market Attractiveness Analysis
12.5.1 By Type
12.5.2 By Application
12.5.3 By Country
13 Competitive Landscape
13.1 Market Players – Competition Matrix
13.2 Market Share Analysis by Key Players, 2020 (%)
13.3 Company Profiles
13.3.1 Abbott
13.3.1.1 Company Overview
13.3.1.2 Company Snapshot
13.3.1.3 Financial Overview
13.3.1.4 Product Portfolio
13.3.1.5 Key Developments/Strategies
13.3.2 ADI/American Diagnostica
13.3.3 Agilent Technologies
13.3.4 Alere/Biosite/Inverness
13.3.5 Axis-Shield
13.3.6 Beckman Coulter/Danaher
13.3.7 Becton Dickinson
13.3.8 Bio/Data
13.3.9 Decode Genetics
13.3.10 Diadexus
13.3.11 Diagnocure
13.3.12 Diagnostica Stago/Trinity Biotech
13.3.13 Diamedix
13.3.14 Polymedco
13.3.15 Qiagen
13.3.16 Roche
13.3.17 SDIX
13.3.18 Sequenom
13.3.19 Siemens
13.3.20 Sienco
13.3.21 Sysmex
13.3.22 Takara Bio
13.3.23 ThermoFisher
13.3.24 Tosoh
13.3.25 Wako
13.3.26 Zycare/Alere
14 Key Takeaways
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
A faster and efficient way to cater to the needs with continuous iteration
Focus on Data Accuracy & Reliability
75+ Clients in Fortune 500
All your transactions are secured end-to-end, ensuring a satisfactory purchase
Ensure the best and affordable pricing
